Sign In
Buy INM
Inmed Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.48M and sold 5.98K INM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 1.48M shares |
| ● Sell | 5.98K shares |
|
80% Buy Activity
Strong Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 27, 2024 Sell |
Woudenberg Michael Chief Operating Officer |
394 Value: $103.7K |
||
|
May 27, 2024 Sell |
Hsu Eric C Sr. Vp, Pre-clinical Res/dev |
545 Value: $143.4K |
||
|
May 27, 2024 Sell |
Adams Eric A President & CEO |
1 139 Value: $299.8K |
||
|
May 27, 2024 Sell |
Adams Eric A President & CEO |
1 139 Value: $299.8K |
||
|
May 27, 2024 Sell |
Hsu Eric C Sr. Vp, Pre-clinical Res/dev |
545 Value: $143.4K |
||
|
May 27, 2024 Sell |
Woudenberg Michael Chief Operating Officer |
394 Value: $103.7K |
||
|
Mar 04, 2024 Sell |
Hsu Eric C Sr. Vp, Pre-clinical Res/dev |
309 Value: $112.7K |
||
|
Mar 04, 2024 Sell |
Hsu Eric C Sr. Vp, Pre-clinical Res/dev |
309 Value: $112.7K |
||
|
Feb 21, 2024 Buy |
Hull Andrew Director |
37 500 Value: $14.6K |
||
|
Feb 21, 2024 Buy |
Hull Andrew Director |
37 500 Value: $14.6K |
||
|
Feb 20, 2024 Buy |
Jagpal Netta Chief Financial Officer |
50 000 Value: $18.5K |
||
|
Feb 20, 2024 Buy |
Jagpal Netta Chief Financial Officer |
50 000 Value: $18.5K |
||
|
Feb 20, 2024 Buy |
Adams Eric A President & CEO |
41 600 Value: $14.9K |
||
|
Feb 20, 2024 Buy |
Adams Eric A President & CEO |
41 600 Value: $14.9K |
||
|
Jan 21, 2024 Sell |
Mancini Alexandra Diane Janet Sr Vp, Clinical Reg Affairs |
121 Value: $37.8K |
||
|
Jan 21, 2024 Sell |
Mancini Alexandra Diane Janet Sr Vp, Clinical Reg Affairs |
121 Value: $37.8K |
||
|
Jan 14, 2024 Sell |
Hull Andrew Director |
42 Value: $12.9K |
||
|
Jan 14, 2024 Sell |
Hull Andrew Director |
42 Value: $12.9K |
||
|
Dec 23, 2023 Buy |
Johnson Shane Aaron Sr Vp & General Manager |
40 000 Value: $14.8K |
||
|
Dec 23, 2023 Buy |
Lemerond Nicole Director |
7 100 Value: $3K |
||
|
Dec 23, 2023 Buy |
Woudenberg Michael Chief Operating Officer |
65 000 Value: $24.1K |
||
|
Dec 23, 2023 Buy |
Tegge Jonathan Interim CFO |
30 000 Value: $11.1K |
||
|
Dec 23, 2023 Buy |
Grove Janet P Director |
7 100 Value: $3K |
||
|
Dec 23, 2023 Buy |
Hsu Eric C Sr. Vp, Pre-clinical Res/dev |
45 000 Value: $16.7K |
||
|
Dec 23, 2023 Buy |
Adams Eric A President & CEO |
136 000 Value: $50.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
